Trogrlić Ivo, Trogrlić Dragan, Trogrlić Zoran
Family business "DREN" Ltd, Žepče, Bosnia & Herzegovina.
Afr J Tradit Complement Altern Med. 2016 Sep 29;13(6):1-4. doi: 10.21010/ajtcam.v13i6.1. eCollection 2016.
The paper presents the results of the use of phytotherapy in a 33-year-old woman who, after finishing the oncological treatment of diffuse astrocytoma, had tumour progression.
Phytotherapy was introduced after the tumour had progressed. It consisted of 4 types of herbal medicine which the subject was taking in form of tea once a day at regular intervals. The patient started phytotherapy along with temozolomide, which was the only oncological treatment she was under after the tumour had progressed. Following the finished chemotherapy, the patient continued the treatment with herbal medicine only. She regularly took phytotherapy without interruption and to the fullest extent for 30 months, and the results of treatment were monitored by periodic scanning using nuclear magnetic resonance technique.
The control scanning that was conducted after the end of combined treatment with temozolomide and phytotherapy showed tumour regression. The patient continued with phytotherapy after finishing chemotherapy and, during the following 24 months, it was the sole treatment option. In that period, the regression of the tumour continued, until a control examination 30 months after the introduction of phytotherapy showed no clinical and radiological signs of tumour.
The results presented in this research paper clearly indicate the potential of phytotherapy in the treatment of some types of brain tumours. A complete regression of tumour following the treatment with nothing but herbal medicine offers support for such claim. Future research should demonstrate the effectiveness of phytotherapy, as a supplementary form of brain tumour treatment, and the results of this research should be compared with the existing information on the effectiveness of the protocols currently used in the treatment of these types of tumour.
本文介绍了植物疗法在一名33岁女性患者中的应用结果，该患者在完成弥漫性星形细胞瘤的肿瘤治疗后出现肿瘤进展。
肿瘤进展后引入植物疗法。它由4种草药组成，受试者每天定期以茶的形式服用一次。患者在肿瘤进展后开始服用植物疗法，同时服用替莫唑胺，这是她在肿瘤进展后接受的唯一肿瘤治疗。化疗结束后，患者仅继续服用草药进行治疗。她持续规律地进行了30个月的植物疗法，且未中断，治疗结果通过使用核磁共振技术的定期扫描进行监测。
在替莫唑胺和植物疗法联合治疗结束后进行的对照扫描显示肿瘤消退。化疗结束后患者继续进行植物疗法，在接下来的24个月里，这是唯一的治疗选择。在此期间，肿瘤持续消退，直到植物疗法开始30个月后的对照检查显示没有肿瘤的临床和放射学迹象。
本研究论文呈现的结果清楚地表明了植物疗法在治疗某些类型脑肿瘤方面的潜力。仅用草药治疗后肿瘤完全消退就支持了这一说法。未来的研究应证明植物疗法作为脑肿瘤治疗的一种补充形式的有效性，并且应将本研究的结果与目前用于治疗这些类型肿瘤的方案有效性的现有信息进行比较。
